The purpose of the study is to evaluate the safety and effectiveness of the HeartMate 3 (HM3) Left Ventricular Assist System (LVAS). This multicenter study is designed to determine if the HM3 provides similar survival and quality of life benefits as the HeartMate(R) II (HMII). Study participants will either receive the HMII Left Ventricular Assist Device (LVAD) or the HM3, the next generation of mechanical support device.
Who may be Eligible
Advanced heart failure patient with shortness of breath upon mild physical activity or who are resistant to advanced heart failure management.